Evidence map›Paper›PMID 41422054›Full record

ArticleStem cell research & therapy2025

Intestinal stem and progenitor cells exhibit distinct adaptive responses to inflammatory stress in IBD.

Brinda Balasubramanian, Shivam Patel, Louis Gall, Nicholas R F Hannan, William Dalleywater, Joerg Huelsken, Carmen Pin, Gordon W Moran, Paloma Ordóñez-Morán

Abstract read
In one paragraph

Article in Stem cell research & therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Brinda BalasubramanianTranslational Medical Sciences Unit, Centre for Cancer Sciences, Biodiscovery Institute, School of Medicine, University of Nottingham, Nottingham, UK.
Shivam PatelTranslational Medical Sciences Unit, Centre for Cancer Sciences, Biodiscovery Institute, School of Medicine, University of Nottingham, Nottingham, UK.
Louis GallCentre for Systems Modelling & Quantitative Biomedicine (SMQB), University of Birmingham, Birmingham, UK.
Nicholas R F HannanTranslational Medical Sciences, Biodiscovery Institute, School of Medicine, University of Nottingham, Nottingham, NG7 2RD, UK.
William DalleywaterTranslational Medical Sciences Unit, Centre for Cancer Sciences, Biodiscovery Institute, School of Medicine, University of Nottingham, Nottingham, UK.
Joerg HuelskenÉcole Polytechnique Fédérale de Lausanne (EPFL), ISREC (Swiss Institute for Experimental Cancer Research), Lausanne, 1015, Switzerland.
Carmen PinSystems Medicine. CPQP. Clinical Pharmacology and Safety Sciences, R&D. AstraZeneca, Cambridge, UK.
Gordon W MoranTranslational Medical Sciences, School of Medicine, Faculty of Medicine and Health Sciences, University of Nottingham; NIHR Nottingham Biomedical Research Centre, Nottingham, UK.
Paloma Ordóñez-MoránTranslational Medical Sciences Unit, Centre for Cancer Sciences, Biodiscovery Institute, School of Medicine, University of Nottingham, Nottingham, UK. paloma.ordonezmoran@nottingham.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIntestinal epithelial stem cells (SCs) and their transit-amplifying (TA) progeny are critical for mucosal repair and regeneration. However, their behaviour under chronic inflammatory conditions, such as those observed in Inflammatory Bowel Disease (IBD), remains incompletely understood.

methodsWe investigated the impact of chronic inflammation on intestinal stem/progenitor cells by integrating bulk RNA sequencing from the largest IBD biopsy cohort to date with single-cell transcriptomic analysis and experimental assays using patient-derived intestinal organoids.

resultsActive inflammation was associated with a reduction in canonical LGR5⁺ intestinal stem cells and a concurrent expansion of OLFM4⁺ populations, consistent with an inflammation-induced epithelial repair program. Notably, SC/TA cells from both inflamed and non-inflamed IBD tissues exhibited persistent transcriptional changes that were distinct from those in healthy controls. Single-cell analysis identified transcriptionally heterogeneous SC/TA subpopulations, including a previously uncharacterized inflammation-associated cluster enriched in immune signalling pathways. Pseudotime trajectory analysis demonstrated a shift in differentiation toward deep crypt secretory (Paneth-like) cell lineages under inflammatory conditions.

conclusionsChronic intestinal inflammation reshapes the epithelial stem and progenitor cell compartment, promoting altered differentiation and the emergence of immune-responsive epithelial states. These findings highlight the plasticity of the human intestinal epithelium in IBD and point to new avenues for therapeutic strategies aimed at maintaining epithelial integrity during chronic inflammation.

Indexed as

InflammationInflammatory Bowel DiseasesIntestinal MucosaStem CellsCell DifferentiationFemaleHumansMaleOrganoidsSingle-Cell AnalysisBEST4BiomarkersGene expressionInflammationInflammation bowel diseaseOrganoidProgenitorsRegenerationStem cells

Identifiers

PMID41422054
PMCPMC12879335

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.